# Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid

> **NCT00584935** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 3 (actual)

## Conditions studied

- Ocular Cicatricial Pemphigoid

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00584935
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584935, "Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00584935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*